bg
A

Agios (AGIO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Agios (AGIO)

Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more

  • USD23.29
  • USD25.07
  • USD22.24
  • USD62.45
  • 7.50%
  • 45M
  • 24.78k
  • 590.63k
  • 2.5B
  • 23.42
  • -14.00%